US SB4635 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 8 2024 - 25% progression
Action: 2024-07-08 - Read twice and referred to the Committee on Armed Services.
Pending: Senate Armed Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 8 2024 - 25% progression
Action: 2024-07-08 - Read twice and referred to the Committee on Armed Services.
Pending: Senate Armed Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require a report and updated guidance on continued risk management for pharmaceutical supply chains of Department of Defense.
Title
Pharmaceutical Risk Assessment and Mitigation Act of 2024
Sponsors
| Sen. Gary Peters [D-MI] | Sen. Joni Ernst [R-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-07-08 | Senate | Read twice and referred to the Committee on Armed Services. |
Same As/Similar To
SB4638 (Related) 2024-07-08 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 433.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/4635/all-info |
| Text | https://www.congress.gov/118/bills/s4635/BILLS-118s4635is.pdf |
